These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 8935599)

  • 21. The role of somatostatin analogs in Cushing's disease.
    van der Hoek J; Lamberts SW; Hofland LJ
    Pituitary; 2004; 7(4):257-64. PubMed ID: 16132202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of somatostatin analogues in the treatment of hypophyseal adenomas].
    Losa M; Mortini P; Giovanelli M
    Minerva Endocrinol; 2003 Mar; 28(1):39-51. PubMed ID: 12621362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-alpha versus somatostatin or the combination of both in gastro-enteropancreatic tumours.
    Oberg K
    Digestion; 1996; 57 Suppl 1():81-3. PubMed ID: 8813477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin and somatostatin receptors in Cushing's disease.
    Hofland LJ
    Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of somatostatin analogues in the treatment of neuroendocrine tumours.
    Grozinsky-Glasberg S; Grossman AB; Korbonits M
    Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly.
    Colao A; Pivonello R; Cappabianca P; Briganti F; Tortora F; Auriemma RS; De Martino MC; Marzullo P; Lombardi G
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):342-9. PubMed ID: 16117824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules.
    Massironi S; Conte D; Rossi RE
    Scand J Gastroenterol; 2016; 51(5):513-23. PubMed ID: 26605828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin analogues in the treatment of endocrine tumors of the gastrointestinal tract.
    Arnold R; Wied M; Behr TH
    Expert Opin Pharmacother; 2002 Jun; 3(6):643-56. PubMed ID: 12472080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors.
    Enzler T; Fojo T
    Semin Oncol; 2017 Apr; 44(2):141-156. PubMed ID: 28923213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New medical treatments in pituitary adenomas].
    Drutel A; Caron P; Archambeaud F
    Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of gastroenteropancreatic neuroendocrine tumors with somatostatin analogues.
    Khagi S; Saif MW
    JOP; 2014 Jul; 15(4):295-8. PubMed ID: 25076324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and function of somatostatin receptors in growth hormone control.
    Shimon I; Melmed S
    J Endocrinol; 1997 Oct; 155 Suppl 1():S3-6; discussion S7-8. PubMed ID: 9389989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When and How to Use Somatostatin Analogues.
    de Herder WW
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):549-555. PubMed ID: 30098715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin receptor imaging: predictive and prognostic considerations.
    Anthony LB; Martin W; Delbeke D; Sandler M
    Digestion; 1996; 57 Suppl 1():50-3. PubMed ID: 8813470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
    Kvols LK; Reubi JC; Horisberger U; Moertel CG; Rubin J; Charboneau JW
    Yale J Biol Med; 1992; 65(5):505-18; discussion 531-6. PubMed ID: 1364090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome.
    Colao A; Pivonello R; Di Somma C; Tauchmanovà L; Savastano S; Lombardi G
    Clin Endocrinol (Oxf); 2007 May; 66(5):714-22. PubMed ID: 17388794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic ectopic Cushing's syndrome and somatostatin analogue treatment.
    Falhammar H
    N Z Med J; 2009 Apr; 122(1294):92-5. PubMed ID: 19465952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medical treatment of pituitary adenoma].
    Chanson P
    Rev Prat; 1996 Jun; 46(12):1509-13. PubMed ID: 8881166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.